| Reduced Risk Status: |
|
| IPM Compatibility: |
Per Requester: Very Good Fit; The commercial product, Sefina, has no pollinator restrictions, allowing it to be used during bloom, which is a critical time point in the management of lebbeck mealybug. It also has known efficacy on several other piercing-sucking insects in citrus therefore can impact more than one pest population when applied. This product has not yet been tested for efficacy or necessary dosage against lebbeck mealybug;09/23
|
| Reasons for need: |
Hibiscus (lebbeck) mealybug; At present, only one chemistry can be applied in the critical bloom period to delay development of this pest and severe fruit drop from it. Afidopyropen would add a chemical tool that can be used in this critical time period:09/23
|
| Requesting State(s): |
FL:Diepenbrock, L* ;
|
| PCR Use Pattern: |
Apply sefina as a foliar spray at a rate advised by the product manufacturer. Desired PHI = 0 days; Preferred RTI: 7 days. Suggested limitations: Do not exceed 28 fl oz per acre per year. Minimum carrier volume is 50 gal for ground applications.
|
| EPA Default Residue Trials: |
3-11 6 10-4
|
| IR-4 Residue Trial Plan: |
3-11 6 10-4
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
BASF requires 3-4 trials are needed to add the pest to the label and that BASF is will cost share (50%) for the E/CS trials and will assist in protocol development:10/23
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
The pcr was received for the commodity, "Citrus", but we are reviewing for "Orange" only since IR-4 already has established PR# 13760 for Lemon & 13761 for Grapefruit. IR-4 has has also asked BASF to consider the "Hibiscus (lebbeck) mealybug" under Lemon too:09/23; BASF is conducting their own residue trials and supports this IR-4 project as "Researchable, E/CS data only":10/23
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|